Chronic Liver Diseases and Liver Cancer: State-of-the Art Progress in 2016

Masakatsu Tsurusaki, Takamichi Murakami, Surgical and Locoregional Therapy of HCC: TACE. Liver cancer. ,vol. 4, pp. 165- 175 ,(2015) , 10.1159/000367739

Tae Wook Kang, Hyunchul Rhim, Recent Advances in Tumor Ablation for Hepatocellular Carcinoma Liver cancer. ,vol. 4, pp. 176- 187 ,(2015) , 10.1159/000367740

Tadaaki Arizumi, Kazuomi Ueshima, Tomohiro Minami, Masashi Kono, Hirokazu Chishina, Masahiro Takita, Satoshi Kitai, Tatsuo Inoue, Norihisa Yada, Satoru Hagiwara, Yasunori Minami, Toshiharu Sakurai, Naoshi Nishida, Masatoshi Kudo, Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma Liver cancer. ,vol. 4, pp. 253- 262 ,(2015) , 10.1159/000367743

Markus Peck-Radosavljevic, Drug therapy for advanced-stage liver cancer. Liver cancer. ,vol. 3, pp. 125- 131 ,(2014) , 10.1159/000343868

Masatoshi Kudo, Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan. Liver cancer. ,vol. 4, pp. 39- 50 ,(2015) , 10.1159/000367727

Wei Teng, Ka-Wai Liu, Chen-Chun Lin, Wen-Juei Jeng, Wei-Ting Chen, I-Shyan Sheen, Chun-Yen Lin, Shi-Ming Lin, Insufficient ablative margin determined by early computed tomography may predict the recurrence of hepatocellular carcinoma after radiofrequency ablation. Liver cancer. ,vol. 4, pp. 26- 38 ,(2015) , 10.1159/000343877

Jean-Luc Raoul, Marine Gilabert, Gilles Piana, How to define transarterial chemoembolization failure or refractoriness: a European perspective. Liver cancer. ,vol. 3, pp. 119- 124 ,(2014) , 10.1159/000343867

Riccardo Lencioni, Thierry de Baere, Robert C. Martin, Charles W. Nutting, Govindarajan Narayanan, Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective. Liver cancer. ,vol. 4, pp. 208- 214 ,(2015) , 10.1159/000367747

Locoregional Therapy for Hepatocellular Carcinoma. Liver cancer. ,vol. 4, pp. 163- 164 ,(2015) , 10.1159/000367741

Immune Checkpoint Blockade in Hepatocellular Carcinoma Liver cancer. ,vol. 4, pp. 201- 207 ,(2015) , 10.1159/000367758